FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3694311000001107: Cyclophosphamide 50mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17574901000001115 Cyclophosphamide 50mg tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17575001000001115 Cyclophosphamide 50mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Is a Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has active ingredient Cyclophosphamide false Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has active ingredient Cyclophosphamide monohydrate false Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cyclophosphamide true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has specific active ingredient Cyclophosphamide monohydrate false Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has specific active ingredient Cyclophosphamide monohydrate true Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) Has basis of strength substance Cyclophosphamide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cyclophosphamide 50mg tablets (Pfizer Ltd) 100 tablet Is pack of False Cyclophosphamide 50mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg tablets (Pfizer Ltd) 100 tablet Has AMP True Cyclophosphamide 50mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start